359 related articles for article (PubMed ID: 37557005)
1. Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling.
Fan L; Meng C; Wang X; Wang Y; Li Y; Lv S; Zhang J
Clinics (Sao Paulo); 2023; 78():100263. PubMed ID: 37557005
[TBL] [Abstract][Full Text] [Related]
2. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
Scolletta S; Biagioli B
Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
[TBL] [Abstract][Full Text] [Related]
3. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
[TBL] [Abstract][Full Text] [Related]
4. Cardiac metabolism in heart failure: implications beyond ATP production.
Doenst T; Nguyen TD; Abel ED
Circ Res; 2013 Aug; 113(6):709-24. PubMed ID: 23989714
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.
Akhmedov AT; Rybin V; Marín-García J
Heart Fail Rev; 2015 Mar; 20(2):227-49. PubMed ID: 25192828
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.
Keceli G; Gupta A; Sourdon J; Gabr R; Schär M; Dey S; Tocchetti CG; Stuber A; Agrimi J; Zhang Y; Leppo M; Steenbergen C; Lai S; Yanek LR; O'Rourke B; Gerstenblith G; Bottomley PA; Wang Y; Paolocci N; Weiss RG
Circ Res; 2022 Mar; 130(5):741-759. PubMed ID: 35109669
[TBL] [Abstract][Full Text] [Related]
7. Myocardial substrate metabolism in the normal and failing heart.
Stanley WC; Recchia FA; Lopaschuk GD
Physiol Rev; 2005 Jul; 85(3):1093-129. PubMed ID: 15987803
[TBL] [Abstract][Full Text] [Related]
8. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
Fukushima A; Milner K; Gupta A; Lopaschuk GD
Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
[TBL] [Abstract][Full Text] [Related]
9. Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure.
Meng S; Yu Y; Yu S; Zhu S; Shi M; Xiang M; Ma H
J Cardiovasc Transl Res; 2024 Feb; 17(1):36-55. PubMed ID: 37843752
[TBL] [Abstract][Full Text] [Related]
10. Metabolic remodelling in human heart failure.
Tuunanen H; Knuuti J
Cardiovasc Res; 2011 May; 90(2):251-7. PubMed ID: 21372005
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanism of the Association Between Atrial Fibrillation and Heart Failure Includes Energy Metabolic Dysregulation Due to Mitochondrial Dysfunction.
Ozcan C; Li Z; Kim G; Jeevanandam V; Uriel N
J Card Fail; 2019 Nov; 25(11):911-920. PubMed ID: 31415862
[TBL] [Abstract][Full Text] [Related]
12. [Potential implications of ketone body metabolism changes and ketogenic therapy in the treatment of heart failure].
Wang Q; Yan S; Kuang S; Zhou M; Jiang C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jul; 35(7):769-772. PubMed ID: 37545460
[TBL] [Abstract][Full Text] [Related]
13. Metabolic remodeling in hypertrophied and failing myocardium: a review.
Peterzan MA; Lygate CA; Neubauer S; Rider OJ
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H597-H616. PubMed ID: 28646030
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Energy Metabolism in Heart Failure.
Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
[TBL] [Abstract][Full Text] [Related]
15. Is AMPK the savior of the failing heart?
Kim TT; Dyck JR
Trends Endocrinol Metab; 2015 Jan; 26(1):40-8. PubMed ID: 25439672
[TBL] [Abstract][Full Text] [Related]
16. Myocardial fatty acid metabolism and cardiac performance in heart failure.
Tuunanen H; Ukkonen H; Knuuti J
Curr Cardiol Rep; 2008 Mar; 10(2):142-8. PubMed ID: 18417015
[TBL] [Abstract][Full Text] [Related]
17. Metabolic remodeling of substrate utilization during heart failure progression.
Chen L; Song J; Hu S
Heart Fail Rev; 2019 Jan; 24(1):143-154. PubMed ID: 29789980
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dysfunction and mitochondrial therapies in heart failure.
Wu C; Zhang Z; Zhang W; Liu X
Pharmacol Res; 2022 Jan; 175():106038. PubMed ID: 34929300
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial involvement in myocyte death and heart failure.
Goldenthal MJ
Heart Fail Rev; 2016 Mar; 21(2):137-55. PubMed ID: 26886225
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure.
Pepin ME; Drakos S; Ha CM; Tristani-Firouzi M; Selzman CH; Fang JC; Wende AR; Wever-Pinzon O
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H674-H684. PubMed ID: 31298559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
